UBS raised the firm’s price target on Houlihan Lokey to $157 from $145 and keeps a Buy rating on the shares. Data points continue to support a cap markets recovery, while wealth management multiples have recovered, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI: